ImetelChat

Great find Biopearl! Pretty complicated stuff this telomerase inhibition. Looks like much research ahead for other inhibitors and Geron should be on the ground floor for development of those for other cancers.

It looks to me like Geron has more money now than it did last December GERON CORPORATION Condensed consolidated balance sheets • Launched RYTELO commercially in the U.S., with $780K in net product revenue for the quarter • Approximately $430 million in cash, cash equivalents and marketable securitie...

From DVS website you posted: Uses This medication is used to treat anemia in patients with a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS). Imetelstat works by slowing or stopping the growth of cancer cells. This effect may help reduce the need for blood transfusions. This see...

yeah, I see emphasis on solid tumors.

I believe the release of agenda is available today. Anyone have access?

Thanks, HI! Interesting but hard to understand and it is just with mice. So this is the oral dosage we have been waiting for?

Definitely deafening applause and cheering. : }

Try this link: https://www.biopharmcatalyst.com/sign-u ... ter_banner

https://mail.google.com/mail/u/0/?pli=1 ... FWsGlKnHMq

Maybe someone wants to spring for a subscription and fill us in on sales?

That's quite the scoop Hunt. I'd give it more than a dot. More like a series of three dots.

August 22nd afterhours: FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 261,000 shares of Geron common stock as inducements to newly hired...

I would think ABBVIE and Bristol Myers would be quite happy if their drug worked nicely in combination with Imetelstat. More consumption 0f their drugs means more retail income.

Revenues Total product revenue, net for the three and six months ended June 30, 2024, was approximately $780,000. Total net revenues for the three and six months ended June 30, 2024, were $882,000 and $1.2 million, compared to $29,000 and $50,000 for the same periods in 2023. The increase in revenue...

“We are thrilled to have begun the launch of RYTELO, our first commercial product, in June, and are encouraged by the early success we are seeing and the reception from the medical community over these first six weeks," said John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer. "Our ...

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia

06/24/24

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in O...

Perhaps significant that he does not have a new job. Just pursuing other possibilities/interests. Possibly internal descension at Geron? Getting old and tired and wants to do wood carving? Family issues that require full attention? Possibly clearing out in preparation for layoffs when a merger occur...

Bad conference. It sounds like a political rally. Lots of distortions, half-truths, data bending. SAD! Clearly they are feeling threatened by Imetelstat.

I am not sure what this is all about, but I hope to tune in to some of it. CTAF July 2024 Public Meeting on Imet… View on Google Calendar When Fri Jul 19, 2024 11am – 5pm (CDT) Where https://events.zoom.us/ej/AsBNl6dH-ZD1YoOp7iCMKaPEtcTQk_ZzRcEd2Zld7djr2kGfGGGS~A8GPxgay3EVDVivs-7aMh60i5V63SSOwB-rF9_...

It's never easy to get your money. I got two settlement checks for two separate IRA accounts and the bank Wells F. insisted we had to deposit the checks into the IRA accounts listed on the checks. That required FED Ex checks to broker in another state as no brokers where we summer. The other two che...